Data Bridge Market Research analyses that the allogenic stem cell therapy market, which was USD 994.9 million in 2022, is expected to reach USD 2109.50 million by 2030, at a CAGR of 9.85% during the forecast period 2023 to 2030.
The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic decisions....
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek